|
2024-01-18 |
2024-01-16 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
37,815
-44.9%
359.25
US$843,750
|
37,815
-44.9%
|
359.25
|
US$843,750
|
|
|
2024-01-18 |
2024-01-16 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
93,998
+0.7%
428.36
US$1,409,119
|
93,998
+0.7%
|
428.36
|
US$1,409,119
|
|
|
2024-01-18 |
2024-01-16 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
4,507
+11.2%
76.07
US$1,100,700
|
4,507
+11.2%
|
76.07
|
US$1,100,700
|
|
|
2024-01-18 |
2024-01-16 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
966
-0.8%
59.02
US$57,013
|
966
-0.8%
|
59.02
|
US$57,013
|
|
|
2024-01-09 |
2024-01-08 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
2,090
-1.7%
58.92
US$123,143
|
2,090
-1.7%
|
58.92
|
US$123,143
|
|
|
2024-01-05 |
2024-01-04 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
1,531
-1.0%
58.81
US$90,038
|
1,531
-1.0%
|
58.81
|
US$90,038
|
|
|
2023-12-19 |
2023-12-18 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
2,387
-1.7%
57.50
US$137,252
|
2,387
-1.7%
|
57.50
|
US$137,252
|
|
|
2023-12-14 |
2023-12-13 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
2,220
-2.1%
56.67
US$125,807
|
2,220
-2.1%
|
56.67
|
US$125,807
|
|
|
2023-09-12 |
2023-09-08 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
2,388
-1.6%
35.63
US$85,084
|
2,388
-1.6%
|
35.63
|
US$85,084
|
|
|
2023-08-15 |
2023-08-11 |
B
Purchase
|
See remarks
|
1,201,440
+60.1%
27.80
US$33,400,032
|
1,201,440
+60.1%
|
27.80
|
US$33,400,032
|
|
|
2023-08-15 |
2023-08-11 |
B
Purchase
|
See remarks
|
57,533
+25.0%
27.80
US$1,599,417
|
57,533
+25.0%
|
27.80
|
US$1,599,417
|
|
|
2023-08-15 |
2023-08-11 |
B
Purchase
|
See remarks
|
1,201,440
+60.1%
27.80
US$33,400,032
|
1,201,440
+60.1%
|
27.80
|
US$33,400,032
|
|
|
2023-08-15 |
2023-08-11 |
B
Purchase
|
See remarks
|
57,533
+25.0%
27.80
US$1,599,417
|
57,533
+25.0%
|
27.80
|
US$1,599,417
|
|
|
2023-08-14 |
2023-08-11 |
B
Purchase
|
Non-Executive Director
|
10,791
+inf%
27.80
US$299,990
|
10,791
+inf%
|
27.80
|
US$299,990
|
|
|
2023-06-02 |
2023-06-02 |
S
Sale
|
Chief Financial Officer
Officer
|
4,647
-5.5%
37.06
US$172,218
|
4,647
-5.5%
|
37.06
|
US$172,218
|
|
|
2023-05-24 |
2023-05-24 |
S
Sale
|
EVP & Chief Scientific Officer
Officer
|
619
-0.5%
45.29
US$28,035
|
619
-0.5%
|
45.29
|
US$28,035
|
|
|
2023-01-20 |
2023-01-18 |
PlS
Planned sale
|
Non-Executive Director
|
2,546
-100.0%
44.66
US$113,704
|
2,546
-100.0%
|
44.66
|
US$113,704
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
Chief Executive Officer
Executive Director
|
3,179
-4.9%
42.38
US$134,715
|
3,179
-4.9%
|
42.38
|
US$134,715
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
619
-1.3%
42.38
US$26,234
|
619
-1.3%
|
42.38
|
US$26,234
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
947
-1.9%
42.38
US$40,132
|
947
-1.9%
|
42.38
|
US$40,132
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
887
-0.9%
42.38
US$37,593
|
887
-0.9%
|
42.38
|
US$37,593
|
|
|
2023-01-19 |
2023-01-17 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
1,358
-1.4%
42.38
US$57,549
|
1,358
-1.4%
|
42.38
|
US$57,549
|
|
|
2023-01-10 |
2023-01-09 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
2,088
-4.1%
45.37
US$94,733
|
2,088
-4.1%
|
45.37
|
US$94,733
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
President,Founder,Head of R&D
Executive Director
|
3,648
-2.1%
46.60
US$169,997
|
3,648
-2.1%
|
46.60
|
US$169,997
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
1,949
-1.9%
46.60
US$90,823
|
1,949
-1.9%
|
46.60
|
US$90,823
|
|
|
2022-12-21 |
2022-12-21 |
S
Sale
|
President,Founder,Head of R&D
Executive Director
|
9,092
-5.0%
40.42
US$367,469
|
9,092
-5.0%
|
40.42
|
US$367,469
|
|
|
2022-12-21 |
2022-12-21 |
S
Sale
|
Chief Executive Officer
Executive Director
|
4,616
-6.6%
40.41
US$186,552
|
4,616
-6.6%
|
40.41
|
US$186,552
|
|
|
2022-12-21 |
2022-12-21 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
3,248
-6.0%
40.41
US$131,266
|
3,248
-6.0%
|
40.41
|
US$131,266
|
|
|
2022-12-20 |
2022-12-16 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
2,410
-2.3%
43.00
US$103,624
|
2,410
-2.3%
|
43.00
|
US$103,624
|
|
|
2022-12-05 |
2022-12-02 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
1,726
-1.6%
90.19
US$155,667
|
1,726
-1.6%
|
90.19
|
US$155,667
|
|
|
2022-11-28 |
2022-11-28 |
PlS
Planned sale
|
President,Founder,Head of R&D
Executive Director
|
69,256
-35.1%
100.00
US$6,925,600
|
69,256
-35.1%
|
100.00
|
US$6,925,600
|
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
Non-Executive Director
|
4,893
-44.8%
85.96
US$420,612
|
4,893
-44.8%
|
85.96
|
US$420,612
|
|
|
2022-08-16 |
2022-08-12 |
S
Sale
|
Non-Executive Director
|
5,107
-31.9%
85.04
US$434,287
|
5,107
-31.9%
|
85.04
|
US$434,287
|
|
|
2022-06-14 |
2022-05-23 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
624
-0.7%
63.54
US$39,649
|
624
-0.7%
|
63.54
|
US$39,649
|
|
|
2022-02-14 |
2022-02-11 |
PlS
Planned sale
|
Non-Executive Director
|
210
-3.4%
106.34
US$22,332
|
210
-3.4%
|
106.34
|
US$22,332
|
|
|
2022-02-14 |
2022-02-11 |
PlS
Planned sale
|
Non-Executive Director
|
8,700
-58.3%
105.80
US$920,428
|
8,700
-58.3%
|
105.80
|
US$920,428
|
|
|
2022-02-14 |
2022-02-11 |
PlS
Planned sale
|
Non-Executive Director
|
2,090
-12.3%
104.76
US$218,958
|
2,090
-12.3%
|
104.76
|
US$218,958
|
|
|
2022-01-20 |
2022-01-19 |
PlS
Planned sale
|
Non-Executive Director
|
1,475
-36.7%
116.07
US$171,203
|
1,475
-36.7%
|
116.07
|
US$171,203
|
|
|
2022-01-18 |
2022-01-18 |
S
Sale
|
President,Founder,Head of R&D
Executive Director
|
2,517
-1.9%
120.48
US$303,253
|
2,517
-1.9%
|
120.48
|
US$303,253
|
|
|
2022-01-18 |
2022-01-18 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
627
-1.8%
120.48
US$75,543
|
627
-1.8%
|
120.48
|
US$75,543
|
|
|
2022-01-18 |
2022-01-18 |
S
Sale
|
SVP, Chief Accounting Officer
Officer
|
533
-3.4%
120.48
US$64,217
|
533
-3.4%
|
120.48
|
US$64,217
|
|
|
2022-01-18 |
2022-01-18 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
627
-0.7%
120.51
US$75,558
|
627
-0.7%
|
120.51
|
US$75,558
|
|
|
2022-01-07 |
2022-01-07 |
S
Sale
|
EVP, Chief Commercial Officer
Officer
|
1,964
-7.3%
135.94
US$266,984
|
1,964
-7.3%
|
135.94
|
US$266,984
|
|
|
2022-01-07 |
2022-01-07 |
S
Sale
|
SVP, Chief Accounting Officer
Officer
|
345
-3.2%
135.94
US$46,900
|
345
-3.2%
|
135.94
|
US$46,900
|
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
1,442
-1.8%
147.72
US$213,017
|
1,442
-1.8%
|
147.72
|
US$213,017
|
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
SVP, Chief Accounting Officer
Officer
|
758
-6.5%
147.74
US$111,987
|
758
-6.5%
|
147.74
|
US$111,987
|
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
President,Founder,Head of R&D
Executive Director
|
69
-0.1%
149.09
US$10,287
|
69
-0.1%
|
149.09
|
US$10,287
|
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
President,Founder,Head of R&D
Executive Director
|
4,045
-3.8%
147.73
US$597,568
|
4,045
-3.8%
|
147.73
|
US$597,568
|
|
|
2021-12-07 |
2021-12-06 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
9
-0.0%
132.00
US$1,188
|
9
-0.0%
|
132.00
|
US$1,188
|
|
|
2021-12-07 |
2021-12-06 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
1,192
-2.0%
130.78
US$155,890
|
1,192
-2.0%
|
130.78
|
US$155,890
|
|
|
2021-12-03 |
2021-12-03 |
PlS
Planned sale
|
President & Head of R&D
Executive Director
|
985
-0.9%
137.56
US$135,495
|
985
-0.9%
|
137.56
|
US$135,495
|
|
|
2021-12-03 |
2021-12-03 |
PlS
Planned sale
|
President & Head of R&D
Executive Director
|
1,210
-1.1%
136.66
US$165,361
|
1,210
-1.1%
|
136.66
|
US$165,361
|
|
|
2021-12-03 |
2021-12-03 |
PlS
Planned sale
|
President & Head of R&D
Executive Director
|
6,558
-5.4%
135.64
US$889,539
|
6,558
-5.4%
|
135.64
|
US$889,539
|
|
|
2021-12-03 |
2021-12-03 |
PlS
Planned sale
|
President & Head of R&D
Executive Director
|
3,842
-3.1%
134.57
US$517,023
|
3,842
-3.1%
|
134.57
|
US$517,023
|
|
|
2021-12-03 |
2021-12-03 |
PlS
Planned sale
|
President & Head of R&D
Executive Director
|
3,900
-3.0%
133.27
US$519,744
|
3,900
-3.0%
|
133.27
|
US$519,744
|
|
|
2021-12-03 |
2021-12-03 |
PlS
Planned sale
|
President & Head of R&D
Executive Director
|
21,509
-14.3%
132.49
US$2,849,721
|
21,509
-14.3%
|
132.49
|
US$2,849,721
|
|
|
2021-12-03 |
2021-12-03 |
PlS
Planned sale
|
President & Head of R&D
Executive Director
|
9,200
-5.8%
131.61
US$1,210,804
|
9,200
-5.8%
|
131.61
|
US$1,210,804
|
|
|
2021-06-21 |
2021-06-18 |
PlS
Planned sale
|
President & CEO
Executive Director
|
1,023
-0.9%
166.73
US$170,566
|
1,023
-0.9%
|
166.73
|
US$170,566
|
|
|
2021-06-21 |
2021-06-18 |
PlS
Planned sale
|
President & CEO
Executive Director
|
20,823
-15.5%
166.07
US$3,457,986
|
20,823
-15.5%
|
166.07
|
US$3,457,986
|
|
|
2021-06-21 |
2021-06-18 |
PlS
Planned sale
|
President & CEO
Executive Director
|
13,338
-9.0%
164.90
US$2,199,499
|
13,338
-9.0%
|
164.90
|
US$2,199,499
|
|
|
2021-06-21 |
2021-06-18 |
PlS
Planned sale
|
President & CEO
Executive Director
|
4,816
-3.2%
164.07
US$790,182
|
4,816
-3.2%
|
164.07
|
US$790,182
|
|
|
2021-05-25 |
2021-05-24 |
S
Sale
|
EVP, Chief Scientific Officer
Officer
|
435
-0.8%
154.34
US$67,138
|
435
-0.8%
|
154.34
|
US$67,138
|
|
|
2021-04-06 |
2021-04-05 |
PlS
Planned sale
|
Non-Executive Director
|
282
-7.5%
180.00
US$50,760
|
282
-7.5%
|
180.00
|
US$50,760
|
|
|
2021-04-06 |
2021-04-05 |
PlS
Planned sale
|
Non-Executive Director
|
1,968
-34.4%
176.70
US$347,747
|
1,968
-34.4%
|
176.70
|
US$347,747
|
|
|
2021-03-22 |
2021-03-19 |
PlS
Planned sale
|
EVP, Chief Commercial Officer
Officer
|
431
-1.6%
177.71
US$76,591
|
431
-1.6%
|
177.71
|
US$76,591
|
|
|
2021-03-22 |
2021-03-19 |
PlS
Planned sale
|
EVP, Chief Commercial Officer
Officer
|
1,350
-4.7%
176.42
US$238,171
|
1,350
-4.7%
|
176.42
|
US$238,171
|
|
|
2021-03-22 |
2021-03-19 |
PlS
Planned sale
|
EVP, Chief Commercial Officer
Officer
|
588
-2.0%
175.54
US$103,216
|
588
-2.0%
|
175.54
|
US$103,216
|
|
|
2021-03-10 |
2021-03-10 |
S
Sale
|
Large shareholder
|
1
-0.0%
195.90
US$196
|
1
-0.0%
|
195.90
|
US$196
|
|
|
2021-03-10 |
2021-03-10 |
S
Sale
|
Large shareholder
|
200
-0.0%
198.00
US$39,600
|
200
-0.0%
|
198.00
|
US$39,600
|
|
|
2021-03-10 |
2021-03-10 |
S
Sale
|
Large shareholder
|
20
-0.0%
196.12
US$3,922
|
20
-0.0%
|
196.12
|
US$3,922
|
|
|
2021-03-10 |
2021-03-10 |
S
Sale
|
Large shareholder
|
189
-0.0%
195.52
US$36,953
|
189
-0.0%
|
195.52
|
US$36,953
|
|
|
2021-03-10 |
2021-03-09 |
S
Sale
|
Large shareholder
|
1
-0.0%
191.00
US$191
|
1
-0.0%
|
191.00
|
US$191
|
|
|
2021-03-10 |
2021-03-09 |
S
Sale
|
Large shareholder
|
2,237
-0.1%
199.08
US$445,342
|
2,237
-0.1%
|
199.08
|
US$445,342
|
|
|
2021-03-10 |
2021-03-09 |
S
Sale
|
Large shareholder
|
3,993
-0.1%
197.81
US$789,855
|
3,993
-0.1%
|
197.81
|
US$789,855
|
|
|
2021-03-10 |
2021-03-09 |
S
Sale
|
Large shareholder
|
4,633
-0.1%
197.30
US$914,091
|
4,633
-0.1%
|
197.30
|
US$914,091
|
|
